Promoter-Capture Hi-C assays, gene expression, and transcription-factor binding data are used to construct a RUNX1-ETO-dependent dynamic gene regulatory network that maintains acute myeloid leukemia (AML). The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.